All products / DC22348
Zalcitabine
Pack sizes and prices
| Pack size | Price |
|---|---|
| 100 mg | $150 USDRequest a quote → |
| 250 mg | $250 USDRequest a quote → |
| 1 g | $500 USDRequest a quote → |
In stock. Contact our team for lead time, shipping and final quotation.
Product overview
Zalcitabine is a potent nucleoside analogue reverse transcriptase inhibitor used in the treatment of HIV infection.
For research use only. Results depend on experimental conditions and do not constitute a performance guarantee.
Identity and specifications
| Catalog number | DC22348 |
|---|---|
| Product name | Zalcitabine |
| CAS | 7481-89-2 |
| Molecular formula | C9H13N3O3 |
| Molecular weight | 211.2178 |
| Purity | >98% |
| SMILES | O1[C@]([H])(C([H])([H])O[H])C([H])([H])C([H])([H])[C@]1([H])N1C(N=C(C([H])=C1[H])N([H])[H])=O |
Source-listed specifications; the batch COA applies.
Source and product documents
The supplier source is linked below. Contact us for COA, SDS and batch-specific documents.
DC Chemicals — Zalcitabine (DC22348)Source references
Zalcitabine is a dideoxynucleoside antiretroviral agent that is phosphorylated to the active metabolite 2',3'-dideoxycytidine 5'-triphosphate (ddCTP) within both uninfected and HIV-infected cells. At therapeutic concentrations, ddCTP inhibits HIV replication by inhibiting the enzyme reverse transcriptase and terminating elongation of the proviral DNA chain[1]. Zalcitabine exhibits the inhibition effect on the cellular uptake of [3H]-PAH in CHO/hOAT1 cells with an IC50 value of 1.23 mM. Furthermore, the cellular uptake of zalcitabine increased threefold with the enhancement of hOATI activity in CHO/hOAT1 cells[2].
